The Effectiveness of Visual Training in Convergence Insufficiency Patients
1 other identifier
interventional
12
1 country
1
Brief Summary
Convergence insufficiency (CI) is one of the most common binocular vision disorders. The prevalence of CI ranges from 3% to 6% in school-aged children. CI symptoms include visual fatigue, headache, blurred vision, and diplopia and could be caused while using near-distance viewing. These symptoms might become more severe with increasing need to perform near-distance tasks. Long-term visual symptoms could result in a negative impact on learning behaviors and work performance in patients. Nowadays, visual training is the main type of management for CI patients clinically; however, the existing training protocol required patients to make several visits to the clinic for visual training, which might increase the burden for patients and result in higher failures in training. Therefore, this study will use a simple training method by utilizing prisms for CI patients to train at home, then compare visual symptoms and binocular vision after the training. In stage I of this study, investigators will recruit 60 symptomatic CI participants aged 9 to 30 years old to do a 6-week visual training with the prisms (15 min/time, 3 times/week). The post-training outcomes will be collected at week 4 and week 6. In stage II, all of the participants will be randomly divided into the "stop training group" and the "continue training group." The participants in the "continue training group" will have the same 6-week prism training and in the "stop training group" will stop all the prism training during this period. The final post-training outcomes of all the participants will be collected again at week 12. In this study, investigators will investigate the effectiveness of the prisms training for 6 weeks and for 12 weeks on visual symptoms and binocular vision in CI patients, and evaluate whether the training effect will be affected by stopping training after 6 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2022
CompletedFirst Posted
Study publicly available on registry
November 3, 2022
CompletedStudy Start
First participant enrolled
March 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2024
CompletedDecember 3, 2024
March 1, 2023
1.3 years
October 25, 2022
November 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Binocular vision and visual function evaluation
Change from baseline best corrected visual acuity: distance visual acuity measured for each eye at a distance of 6 m and at near 40 cm for each eye will be measured using Snellen charts. NPC and the amplitude of accommodation will be measured using Royal Air Force (RAF) rule. Stereoacuity will be measured by the Random dot stereotest.
12 weeks for each participant
Study Arms (2)
Stop training group
ACTIVE COMPARATORHome-base prism training during week 1-6 --\> then stop training during week 7-12 --\> endpoint data collected at week 12
Continune training group
EXPERIMENTALHome-base prism training during week 1-12 --\> endpoint data collected at week 12
Interventions
Visual training is the main type of management for CI patients clinically; however, the existing training protocol required patients to make several visits to the clinic for visual training, which might increase the burden for patients and result in higher failures in training. Therefore, this study will use a simple training method by utilizing prisms for CI patients to train at home, then compare visual symptoms and binocular vision after the training.
Eligibility Criteria
You may qualify if:
- The overall score of CI symptom survey ≥ 16 (9-18 years old) or ≥ 21 (19-30 years old)
- The break point of near point of convergence (NPC) ≥ 6 cm
- Exophoria at near distances be at least 4∆ higher than at far distances
- Near positive fusional vergence (PFV) ≤ 15∆ or failing Sheard's criterion at near.
You may not qualify if:
- The best corrected visual acuity (BCVA) of \< 20/25 in each eye at far and near distances
- Amblyopia patients or the difference of BCVA between the two eyes ≥ 2 lines
- Constant strabismus patients
- History of strabismus surgery or refractive surgery
- Systemic diseases that would affect binocular vision
- Acquired brain injury or neurological disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei County, 100225, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tzu-Hsun Tsai, PhD
National Taiwan University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2022
First Posted
November 3, 2022
Study Start
March 6, 2023
Primary Completion
June 26, 2024
Study Completion
June 26, 2024
Last Updated
December 3, 2024
Record last verified: 2023-03